Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0277-2025Class II

smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS...

Smith & Nephew, Inc. / initiated 2024-10-02 / Open, Classified / root cause: packaging

Smith & Nephew Inc began a recall of smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED... on . FDA classified it as Class II and gives the reason as "Complaint received indicating that a package contained a LGN OX CONSTRAINED FEM 3 LT implant instead of a LGN OX CONSTRAINED FEM 4 LT as described on the product label". As of , the recall status on record is Open, Classified, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-0277-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Smith & Nephew, Inc.
Product
smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER
Product code
JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
Reason for recall
Complaint received indicating that a package contained a LGN OX CONSTRAINED FEM 3 LT implant instead of a LGN OX CONSTRAINED FEM 4 LT as described on the product label.
Root cause tag
packaging
FDA root cause
Packaging change control
Action
Smith & Nephew issued an "Urgent Medical Device Recall Notice" to its consignees on 10/02/2024 via email. The notice explained the issue, potential risk of use of the affected product, and requested the return of the affected devices. Distributors, sales reps, and district offices were directed to notify their customers. If you have any questions or concerns regarding this recall please contact FieldActions@smith nephew.com.
Quantity in commerce
3 units
Distribution
US Distribution to state of Texas and OUS (foreign) to countries of: Spain, France and United Kingdom,.
Product codes and lots
UDI/DI 03596010543820, Batch Number 23LM00479

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0277-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0277-2025Class IIOngoingVoluntary: Firm initiated
Z-0278-2025Class IIOngoingVoluntary: Firm initiated